2 results
Approved WMOPending
Evaluating the long term safety and tolerability of ranibizumab treatment of AMD patients.
Approved WMORecruiting
To determine the safety, feasibility, and tolerability of adding PIPAC with oxaliplatin (92 mg/m2) to systemic chemotherapy in patients with isolated PM from CRC.